301 - 350 of 6230 Results
Title
Year
- Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder2013OPENTitle: Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorderJournal Name: Sleep MedicinePublisher: Elsevier BVVol: 14Issue #: 8Start Page: 754End Page: 762Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.sleep.2012.10.015Best OA location URL: http://doi.org/10.1016/j.sleep.2012.10.015Citation Count: 375
- An Observational Study of the Effect of Levodopa–Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson’s Disease Patients2017OPENTitle: An Observational Study of the Effect of Levodopa–Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson’s Disease PatientsJournal Name: Advances in TherapyPublisher: Springer Science and Business Media LLCVol: 34Issue #: 7Start Page: 1741End Page: 1752Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12325-017-0571-2Best OA location URL: https://link.springer.com/content/pdf/10.1007%2Fs12325-017-0571-2.pdfCitation Count: 27
- Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, α -Synuclein Synthesis, Interleukin-1β Release, and Cholinergic Action.2013OPENTitle: Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, α -Synuclein Synthesis, Interleukin-1β Release, and Cholinergic Action.Journal Name: Anti-Inflammatory & Anti-Allergy Agents in Medicinal ChemistryPublisher: Bentham Science Publishers Ltd.Vol: 12Issue #: 2Start Page: 117End Page: 128Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2174/1871523011312020003Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5214460Citation Count: 26
-
OPENTitle: Is the N-Back Task a Valid Neuropsychological Measure for Assessing Working Memory?Journal Name: Archives of Clinical NeuropsychologyPublisher: Oxford University Press (OUP)Vol: 24Issue #: 7Start Page: 711End Page: 717Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/arclin/acp063Best OA location URL: https://academic.oup.com/acn/article-pdf/24/7/711/11189/acp063.pdfCitation Count: 210
-
OPENTitle: Radiosynthesis and in Vivo Evaluation of Two PET Radioligands for Imaging α-SynucleinJournal Name: Applied SciencesPublisher: MDPI AGVol: 4Issue #: 1Start Page: 66End Page: 78Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/app4010066Best OA location URL: https://www.mdpi.com/2076-3417/4/1/66/pdf?version=1395063831Citation Count: 53
- Randomized Controlled Trial of a Home-Based Action Observation Intervention to Improve Walking in Parkinson Disease2016OPENTitle: Randomized Controlled Trial of a Home-Based Action Observation Intervention to Improve Walking in Parkinson DiseaseJournal Name: Archives of Physical Medicine and RehabilitationPublisher: Elsevier BVVol: 97Issue #: 5Start Page: 665End Page: 673Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.apmr.2015.12.029Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4844795Citation Count: 45
- Treatment With Cholinesterase Inhibitors and Memantine of Patients in the Alzheimer's Disease Neuroimaging Initiative2011OPENTitle: Treatment With Cholinesterase Inhibitors and Memantine of Patients in the Alzheimer's Disease Neuroimaging InitiativeJournal Name: Archives of NeurologyPublisher: American Medical Association (AMA)Vol: 68Issue #: 1Start Page: 58End Page: 58Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/archneurol.2010.343Citation Count: 150
-
OPENTitle: Reduced Uptake of FDOPA PET in End-stage Liver Disease With Elevated Manganese LevelsJournal Name: Archives of NeurologyPublisher: American Medical Association (AMA)Vol: 69Issue #: 3Start Page: 394End Page: 394Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/archneurol.2011.771Citation Count: 26
-
OPENTitle: Anatomy of graft-induced dyskinesias: Circuit remodeling in the parkinsonian striatumJournal Name: Basal GangliaPublisher: Elsevier BVVol: 2Issue #: 1Start Page: 15End Page: 30Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.baga.2012.01.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3375918Citation Count: 13
-
OPENTitle: Sensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson's diseaseJournal Name: Behavioural Brain ResearchPublisher: Elsevier BVVol: 230Issue #: 2Start Page: 309End Page: 316Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bbr.2011.12.007Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3324279Citation Count: 145
- Pathogenic Parkinson’s disease mutations across the functional domains of LRRK2 alter the autophagic/lysosomal response to starvation2013OPENTitle: Pathogenic Parkinson’s disease mutations across the functional domains of LRRK2 alter the autophagic/lysosomal response to starvationJournal Name: Biochemical and Biophysical Research CommunicationsPublisher: Elsevier BVVol: 441Issue #: 4Start Page: 862End Page: 866Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.bbrc.2013.10.159Best OA location URL: https://doi.org/10.1016/j.bbrc.2013.10.159Citation Count: 82
- From structure to ætiology: a new window on the biology of leucine-rich repeat kinase 2 and Parkinson's disease2021OPENTitle: From structure to ætiology: a new window on the biology of leucine-rich repeat kinase 2 and Parkinson's diseaseJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 478Issue #: 14Start Page: 2945End Page: 2951Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1042/bcj20210383Best OA location URL: https://portlandpress.com/biochemj/article-pdf/478/14/2945/918073/bcj-2021-0383.pdfCitation Count: 5
- α‐synuclein conformational antibodies fused to penetratin are effective in models of Lewy body disease2016OPENTitle: α‐synuclein conformational antibodies fused to penetratin are effective in models of Lewy body diseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 3Issue #: 8Start Page: 588End Page: 606Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.321Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.321Citation Count: 39
-
OPENTitle: The avascular zone and neuronal remodeling of the fovea in Parkinson diseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 2Issue #: 2Start Page: 196End Page: 201Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.146Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.146Citation Count: 41
- Dysregulation of 14‐3‐3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathology2017OPENTitle: Dysregulation of 14‐3‐3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathologyJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 7Start Page: 466End Page: 477Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.421Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.421Citation Count: 37
- Synthesis and SAR of a novel positive allosteric modulator (PAM) of the metabotropic glutamate receptor 4 (mGluR4)2009OPENTitle: Synthesis and SAR of a novel positive allosteric modulator (PAM) of the metabotropic glutamate receptor 4 (mGluR4)Journal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 19Issue #: 17Start Page: 4967End Page: 4970Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2009.07.072Best OA location URL: https://doi.org/10.7270/q2tb16zxCitation Count: 36
- Synthesis and SAR of novel, 4-(phenylsulfamoyl)phenylacetamide mGlu4 positive allosteric modulators (PAMs) identified by functional high-throughput screening (HTS)2010OPENTitle: Synthesis and SAR of novel, 4-(phenylsulfamoyl)phenylacetamide mGlu4 positive allosteric modulators (PAMs) identified by functional high-throughput screening (HTS)Journal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 20Issue #: 17Start Page: 5175End Page: 5178Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2010.07.007Citation Count: 29
- Synthesis and SAR of a novel metabotropic glutamate receptor 4 (mGlu4) antagonist: Unexpected ‘molecular switch’ from a closely related mGlu4 positive allosteric modulator2011OPENTitle: Synthesis and SAR of a novel metabotropic glutamate receptor 4 (mGlu4) antagonist: Unexpected ‘molecular switch’ from a closely related mGlu4 positive allosteric modulatorJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 21Issue #: 23Start Page: 6955End Page: 6959Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2011.09.131Best OA location URL: https://doi.org/10.7270/q2s75grqCitation Count: 18
- Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4): Part I. Discovery of pyrazolo[3,4-d]pyrimidines as novel mGluR4 positive allosteric modulators2008OPENTitle: Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4): Part I. Discovery of pyrazolo[3,4-d]pyrimidines as novel mGluR4 positive allosteric modulatorsJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 18Issue #: 20Start Page: 5626End Page: 5630Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2008.08.087Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3182458Citation Count: 58
-
OPENTitle: Characterization of TAE684 as a potent LRRK2 kinase inhibitorJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 22Issue #: 5Start Page: 1864End Page: 1869Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2012.01.084Best OA location URL: http://hdl.handle.net/10871/35667Citation Count: 85
- Discovery and characterization of a novel series of N -phenylsulfonyl-1 H -pyrrole picolinamides as positive allosteric modulators of the metabotropic glutamate receptor 4 (mGlu 4 )2016OPENTitle: Discovery and characterization of a novel series of N -phenylsulfonyl-1 H -pyrrole picolinamides as positive allosteric modulators of the metabotropic glutamate receptor 4 (mGlu 4 )Journal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 26Issue #: 13Start Page: 2984End Page: 2987Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2016.05.029Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4955388Citation Count: 5
- Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson’s disease2016OPENTitle: Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson’s diseaseJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1186/s12883-016-0610-7Best OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-016-0610-7Citation Count: 55
- Normalization and expression changes in predefined sets of proteins using 2D gel electrophoresis: A proteomic study of L-DOPA induced dyskinesia in an animal model of Parkinson's disease using DIGE2006OPENTitle: Normalization and expression changes in predefined sets of proteins using 2D gel electrophoresis: A proteomic study of L-DOPA induced dyskinesia in an animal model of Parkinson's disease using DIGEJournal Name: BMC BioinformaticsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/1471-2105-7-475Best OA location URL: https://bmcbioinformatics.biomedcentral.com/counter/pdf/10.1186/1471-2105-7-475Citation Count: 38
- MPP+‐dependent inhibition of Ih reduces spontaneous activity and enhances EPSP summation in nigral dopamine neurons2013OPENTitle: MPP+‐dependent inhibition of Ih reduces spontaneous activity and enhances EPSP summation in nigral dopamine neuronsJournal Name: British Journal of PharmacologyPublisher: WileyVol: 169Issue #: 1Start Page: 130End Page: 142Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/bph.12104Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.12104Citation Count: 29
-
OPENTitle: Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1Journal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 34Issue #: 22Start Page: 2840End Page: 2861Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/embj.201591593Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embj.201591593Citation Count: 172
-
OPENTitle: Single-Cell Phenotyping within Transparent Intact Tissue through Whole-Body ClearingJournal Name: CellPublisher: Elsevier BVVol: 158Issue #: 4Start Page: 945End Page: 958Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.cell.2014.07.017Best OA location URL: http://www.cell.com/article/S0092867414009313/pdfCitation Count: 918
-
OPENTitle: Simple, Scalable Proteomic Imaging for High-Dimensional Profiling of Intact SystemsJournal Name: CellPublisher: Elsevier BVVol: 163Issue #: 6Start Page: 1500End Page: 1514Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.cell.2015.11.025Best OA location URL: http://www.cell.com/article/S0092867415015056/pdfCitation Count: 469
- Hybrid Bayesian-rank integration approach improves the predictive power of genomic dataset aggregation2014OPENTitle: Hybrid Bayesian-rank integration approach improves the predictive power of genomic dataset aggregationJournal Name: BioinformaticsPublisher: Oxford University Press (OUP)Vol: 31Issue #: 2Start Page: 209End Page: 215Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/bioinformatics/btu518Best OA location URL: https://academic.oup.com/bioinformatics/article-pdf/31/2/209/17125420/btu518.pdfCitation Count: 20
- Selective Knockout of the Casein Kinase 2 in D1 Medium Spiny Neurons Controls Dopaminergic Function2013OPENTitle: Selective Knockout of the Casein Kinase 2 in D1 Medium Spiny Neurons Controls Dopaminergic FunctionJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 74Issue #: 2Start Page: 113End Page: 121Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2012.11.013Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3878430Citation Count: 40
- The Thorny Problem of Dyskinesias: Dendritic Spines, Synaptic Plasticity, and Striatal Dysfunction2014OPENTitle: The Thorny Problem of Dyskinesias: Dendritic Spines, Synaptic Plasticity, and Striatal DysfunctionJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 75Issue #: 9Start Page: 676End Page: 677Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2014.02.019Best OA location URL: http://doi.org/10.1016/j.biopsych.2014.02.019Citation Count: 1
-
OPENTitle: Efficient estimation of nonparametric genetic risk function with censored dataJournal Name: BiometrikaPublisher: Oxford University Press (OUP)Vol: 102Issue #: 3Start Page: 515End Page: 532Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/biomet/asv030Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4581539Citation Count: 7
- Efficient determination of purine metabolites in brain tissue and serum by high‐performance liquid chromatography with electrochemical and UV detection2012OPENTitle: Efficient determination of purine metabolites in brain tissue and serum by high‐performance liquid chromatography with electrochemical and UV detectionJournal Name: Biomedical ChromatographyPublisher: WileyVol: 27Issue #: 1Start Page: 122End Page: 129Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/bmc.2760Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9979337Citation Count: 27
-
OPENTitle: Identifying blood-brain-barrier selective single-chain antibody fragmentsJournal Name: Biotechnology JournalPublisher: WileyVol: 9Issue #: 5Start Page: 664End Page: 674Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/biot.201300550Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4073886Citation Count: 23
- Toxic Oligomeric Alpha-Synuclein Variants Present in Human Parkinson’s Disease Brains Are Differentially Generated in Mammalian Cell Models2015OPENTitle: Toxic Oligomeric Alpha-Synuclein Variants Present in Human Parkinson’s Disease Brains Are Differentially Generated in Mammalian Cell ModelsJournal Name: BiomoleculesPublisher: MDPI AGVol: 5Issue #: 3Start Page: 1634End Page: 1651Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom5031634Best OA location URL: https://www.mdpi.com/2218-273X/5/3/1634/pdf?version=1437555461Citation Count: 37
- Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samples2013OPENTitle: Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samplesJournal Name: Biotechnology ProgressPublisher: WileyVol: 29Issue #: 2Start Page: 463End Page: 471Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/btpr.1698Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3618510Citation Count: 24
- Stratification of candidate genes for Parkinson’s disease using weighted protein-protein interaction network analysis2018OPENTitle: Stratification of candidate genes for Parkinson’s disease using weighted protein-protein interaction network analysisJournal Name: BMC GenomicsPublisher: Springer Science and Business Media LLCVol: 19Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s12864-018-4804-9Best OA location URL: https://bmcgenomics.biomedcentral.com/track/pdf/10.1186/s12864-018-4804-9.pdfCitation Count: 42
- Cost effectiveness of preventing falls and improving mobility in people with Parkinson disease: protocol for an economic evaluation alongside a clinical trial2008OPENTitle: Cost effectiveness of preventing falls and improving mobility in people with Parkinson disease: protocol for an economic evaluation alongside a clinical trialJournal Name: BMC GeriatricsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/1471-2318-8-23Best OA location URL: https://bmcgeriatr.biomedcentral.com/track/pdf/10.1186/1471-2318-8-23Citation Count: 31
- Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotension2016OPENTitle: Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotensionJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-016-0665-5Best OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-016-0665-5Citation Count: 4
-
OPENTitle: A grounded theory study on the influence of sleep on Parkinson’s symptomsJournal Name: BMC Research NotesPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13104-016-2114-3Best OA location URL: https://bmcresnotes.biomedcentral.com/track/pdf/10.1186/s13104-016-2114-3Citation Count: 4
-
OPENTitle: Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairmentJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1186/s12883-015-0403-4Best OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-015-0403-4Citation Count: 51
- Exercise response in Parkinson’s disease: insights from a cross-sectional comparison with sedentary controls and a per-protocol analysis of a randomised controlled trial2017OPENTitle: Exercise response in Parkinson’s disease: insights from a cross-sectional comparison with sedentary controls and a per-protocol analysis of a randomised controlled trialJournal Name: BMJ OpenPublisher: BMJVol: 7Issue #: 12Start Page: e017194End Page: e017194Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjopen-2017-017194Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/7/12/e017194.full.pdfCitation Count: 32
- Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease2012OPENTitle: Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's diseaseJournal Name: British Journal of Clinical PharmacologyPublisher: WileyVol: 74Issue #: 2Start Page: 284End Page: 295Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1365-2125.2012.04208.xCitation Count: 43
-
OPENTitle: Swallowing Outcomes Following Unilateral STN vs. GPi Surgery: A Retrospective AnalysisJournal Name: DysphagiaPublisher: Springer Science and Business Media LLCVol: 29Issue #: 4Start Page: 425End Page: 431Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00455-014-9522-0Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4127154Citation Count: 43
- Alpha-Synuclein Pathology in Sensory Nerve Terminals of the Upper Aerodigestive Tract of Parkinson’s Disease Patients2015OPENTitle: Alpha-Synuclein Pathology in Sensory Nerve Terminals of the Upper Aerodigestive Tract of Parkinson’s Disease PatientsJournal Name: DysphagiaPublisher: Springer Science and Business Media LLCVol: 30Issue #: 4Start Page: 404End Page: 417Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00455-015-9612-7Best OA location URL: http://doi.org/10.1007/s00455-015-9612-7Citation Count: 40
- Striatal Overexpression of ΔJunD Resets L-DOPA-Induced Dyskinesia in a Primate Model of Parkinson Disease2009OPENTitle: Striatal Overexpression of ΔJunD Resets L-DOPA-Induced Dyskinesia in a Primate Model of Parkinson DiseaseJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 66Issue #: 6Start Page: 554End Page: 561Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2009.04.005Best OA location URL: http://doi.org/10.1016/j.biopsych.2009.04.005Citation Count: 91
- Spatiotemporal Pattern of Striatal ERK1/2 Phosphorylation in a Rat Model of L-DOPA–Induced Dyskinesia and the Role of Dopamine D1 Receptors2007OPENTitle: Spatiotemporal Pattern of Striatal ERK1/2 Phosphorylation in a Rat Model of L-DOPA–Induced Dyskinesia and the Role of Dopamine D1 ReceptorsJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 62Issue #: 7Start Page: 800End Page: 810Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2006.11.032Best OA location URL: http://doi.org/10.1016/j.biopsych.2006.11.032Citation Count: 272
-
OPENTitle: Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer’s diseaseJournal Name: BiomarkersPublisher: Informa UK LimitedVol: 14Issue #: 7Start Page: 493End Page: 501Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3109/13547500903108423Citation Count: 107
- Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4). Part II: Challenges in hit-to-lead2008OPENTitle: Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4). Part II: Challenges in hit-to-leadJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 19Issue #: 3Start Page: 962End Page: 966Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2008.11.104Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3787871Citation Count: 55
-
OPENTitle: Role of Elongation and Secondary Pathways in S6 Amyloid Fibril GrowthJournal Name: Biophysical JournalPublisher: Elsevier BVVol: 102Issue #: 9Start Page: 2167End Page: 2175Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.bpj.2012.03.047Best OA location URL: http://www.cell.com/article/S0006349512003888/pdfCitation Count: 36
- Conformational heterogeneity of the Roc domains in C. tepidum Roc–COR and implications for human LRRK2 Parkinson mutations2015OPENTitle: Conformational heterogeneity of the Roc domains in C. tepidum Roc–COR and implications for human LRRK2 Parkinson mutationsJournal Name: Bioscience ReportsPublisher: Portland Press Ltd.Vol: 35Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bsr20150128Best OA location URL: https://portlandpress.com/bioscirep/article-pdf/35/5/e00254/477473/bsr035e254.pdfCitation Count: 27